Actelion, Europe's largest biotech company, has the backing of Rudolf Maag, one its largest shareholders, a spokeswoman for Maag said on Monday.
The company is coming under pressure from hedge fund activist Elliott Advisors ahead of the group's annual general meeting in May.
Elliott, Actelion's biggest shareholder with a near 6% stake, is dissatisfied with the group's performance and is pushing Actelion to consider selling itself.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Compelling solutions through strategic partnerships
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
